Detalhe da pesquisa
1.
Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis.
PLoS Pathog
; 19(7): e1011018, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37428793
2.
Design, synthesis, and characterization of novel, nonquaternary reactivators of GF-inhibited human acetylcholinesterase.
Bioorg Med Chem Lett
; 24(7): 1711-4, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24630558
3.
Phase I study of UCN-01 and perifosine in patients with relapsed and refractory acute leukemias and high-risk myelodysplastic syndrome.
Invest New Drugs
; 31(5): 1217-27, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23443507
4.
Preclinical Development of Brain Permeable ERß Agonist for the Treatment of Glioblastoma.
Mol Cancer Ther
; 22(11): 1248-1260, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37493258
5.
Discovery and optimization of novel purines as potent and selective CB2 agonists.
Bioorg Med Chem Lett
; 22(15): 4962-6, 2012 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22765893
6.
Access to care for children with fractures.
J Pediatr Orthop
; 30(3): 244-7, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20357590
7.
Phase I and pharmacokinetic study of Triapine, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies.
Leuk Res
; 31(9): 1165-73, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17324462
8.
Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias.
Clin Cancer Res
; 11(23): 8403-12, 2005 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16322302
9.
Timed sequential therapy of acute leukemia with flavopiridol: in vitro model for a phase I clinical trial.
Clin Cancer Res
; 9(1): 307-15, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12538483
10.
Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: therapy with sequential 1-beta-d-arabinofuranosylcytosine, mitoxantrone, and bevacizumab.
Clin Cancer Res
; 10(11): 3577-85, 2004 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15173063
11.
Lack of objective response of myelodysplastic syndromes and acute myeloid leukemia to decitabine after failure of azacitidine.
Leuk Lymphoma
; 56(6): 1718-22, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25263320
12.
Treatment of catheter-related deep vein thrombosis in patients with acute leukemia with anticoagulation.
Leuk Lymphoma
; 56(7): 2082-6, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25379622
13.
Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment.
Science
; 347(6225): 995-8, 2015 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25722412
14.
Timed sequential therapy of acute myelogenous leukemia in adults: a phase II study of retinoids in combination with the sequential administration of cytosine arabinoside, idarubicin and etoposide.
Leuk Res
; 27(4): 313-21, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12531222
15.
Cyclization of aryl silanes with unexpected retention of silicon.
Org Lett
; 4(22): 3797-8, 2002 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-12599461
16.
A protocol for the management of pediatric type I open fractures.
J Child Orthop
; 8(1): 71-6, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24488846
17.
High frequency of rare structural chromosome abnormalities at relapse of cytogenetically normal acute myeloid leukemia with FLT3 internal tandem duplication.
Cancer Genet
; 207(10-12): 467-73, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25441683
18.
Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapy.
Leuk Lymphoma
; 55(7): 1533-7, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24144313
19.
Tertiary center referral patterns for patients with myelodysplastic syndrome are indicative of age and race disparities: a single-institution experience.
Leuk Lymphoma
; 54(2): 304-9, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22793170
20.
Selective cannabinoid receptor type 2 (CB2) agonists: optimization of a series of purines leading to the identification of a clinical candidate for the treatment of osteoarthritic pain.
J Med Chem
; 56(14): 5722-33, 2013 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23795771